Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2006-09-07

Clinical Trial Update: Combination Therapy (Provigil + Avonex) to Treat Cognitive Problems in MS [NA]

View source ↗

Summary

Clinical trial update evaluating a combination of modafinil (Provigil) and interferon beta-1a (Avonex) to treat cognitive problems in Relapsing-Remitting Multip…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Avonex (Interferon beta-1a)
  • Provigil (Modafinil)

Snippet

Sponsor: Institute for Clinical Research | Conditions: Relapsing-Remitting Multiple Sclerosis | NA | Status: UNKNOWN